ATE271880T1 - Methoden zur behandlung von diabetes - Google Patents
Methoden zur behandlung von diabetesInfo
- Publication number
- ATE271880T1 ATE271880T1 AT00932729T AT00932729T ATE271880T1 AT E271880 T1 ATE271880 T1 AT E271880T1 AT 00932729 T AT00932729 T AT 00932729T AT 00932729 T AT00932729 T AT 00932729T AT E271880 T1 ATE271880 T1 AT E271880T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- type
- diabetes
- symptoms
- treating diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/326,189 US6040292A (en) | 1999-06-04 | 1999-06-04 | Methods for treating diabetes |
PCT/US2000/014163 WO2000074710A2 (en) | 1999-06-04 | 2000-05-23 | Methods for treating diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE271880T1 true ATE271880T1 (de) | 2004-08-15 |
Family
ID=23271175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00932729T ATE271880T1 (de) | 1999-06-04 | 2000-05-23 | Methoden zur behandlung von diabetes |
Country Status (16)
Country | Link |
---|---|
US (1) | US6040292A (de) |
EP (1) | EP1183042B1 (de) |
JP (1) | JP2003501397A (de) |
KR (1) | KR100694737B1 (de) |
CN (1) | CN1235637C (de) |
AT (1) | ATE271880T1 (de) |
AU (1) | AU780400B2 (de) |
CA (1) | CA2373281C (de) |
DE (1) | DE60012517T2 (de) |
ES (1) | ES2222208T3 (de) |
HK (1) | HK1044895A1 (de) |
IL (1) | IL146868A0 (de) |
MX (1) | MXPA01013384A (de) |
NO (1) | NO324117B1 (de) |
WO (1) | WO2000074710A2 (de) |
ZA (1) | ZA200110408B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6040292A (en) * | 1999-06-04 | 2000-03-21 | Celtrix Pharmaceuticals, Inc. | Methods for treating diabetes |
TWI322153B (en) * | 2000-07-03 | 2010-03-21 | Bristol Myers Squibb Co | Methods for treating rheumatic diseases using a soluble ctla4 molecule |
US20040022787A1 (en) | 2000-07-03 | 2004-02-05 | Robert Cohen | Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
AU9109001A (en) * | 2000-09-19 | 2002-04-02 | Bioexpertise Llc | Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
US20040220190A1 (en) * | 2002-07-29 | 2004-11-04 | Cincotta Anthony H. | Methods of treating metabolic syndrome using dopamine receptor agonists |
US20040077679A1 (en) * | 2002-07-29 | 2004-04-22 | Cincotta Anthony H. | Therapeutic treatment for the metabolic syndrome and type 2 diabetes |
US20080200453A1 (en) | 2002-07-29 | 2008-08-21 | Cincotta Anthony H | Methods of treating metabolic syndrome using dopamine receptor agonists |
US9655865B2 (en) | 2002-07-29 | 2017-05-23 | Veroscience, Llc | Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes |
US20040081678A1 (en) * | 2002-08-09 | 2004-04-29 | Anthony Cincotta | Therapeutic process for the treatment of obesity and associated metabolic disorders |
US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
US8137994B2 (en) * | 2004-03-25 | 2012-03-20 | Veroscience Llc | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
US20050215558A1 (en) * | 2004-03-25 | 2005-09-29 | Cincotta Anthony H | Methods of identifying responders to dopamine agonist therapy |
US8137993B2 (en) * | 2004-03-25 | 2012-03-20 | Veroscience Llc | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
JP5743373B2 (ja) * | 2004-12-30 | 2015-07-01 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ネコ食餌用の組成物 |
US8518877B2 (en) * | 2007-04-18 | 2013-08-27 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
WO2010096125A1 (en) * | 2008-10-29 | 2010-08-26 | The Rockefeller University | Methods and kits for treating disease by administering insulin-like growth factor binding protein-2 |
KR101766927B1 (ko) | 2009-04-01 | 2017-08-09 | 제넨테크, 인크. | 인슐린 저항성 장애의 치료 |
US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
JP5938407B2 (ja) | 2010-08-16 | 2016-06-22 | アラーガン、インコーポレイテッドAllergan,Incorporated | α−2Bアドレナリン受容体作動薬を用いて制御性T細胞を活性化する方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200509A (en) * | 1987-04-06 | 1993-04-06 | Celtrix Pharmaceuticals, Inc. | Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
US4988675A (en) * | 1988-02-05 | 1991-01-29 | Ciba-Geigy Corporation | Method for preventing secondary effects |
GB8920381D0 (en) * | 1989-09-08 | 1989-10-25 | Greater Glasgow Health Board | Treatment of insulin-resistant diabetes |
SE9201573D0 (sv) * | 1992-05-19 | 1992-05-19 | Kabi Pharmacia Ab | Use of igf-1 |
NZ255461A (en) * | 1992-08-20 | 1996-12-20 | Biotechnology & Biolog Science | Specific binding molecules for insulin-like-growth-factor-1 (igf-1), antigens capable of generating them and their use in enhancing igf-1 activity |
US5407913A (en) * | 1992-12-03 | 1995-04-18 | Celtrix Pharmaceuticals, Inc. | Method and composition for systemic treatment of tissue injury |
JPH08500123A (ja) * | 1993-01-25 | 1996-01-09 | ザ ベス イスラエル ホスピタル アソシエイション | Igf−i感受性細胞のバリヤー特性の修飾方法,診断方法及びスクリーニング方法 |
US5563046A (en) * | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
DK0723453T3 (da) * | 1993-08-03 | 2000-06-05 | Celtrix Pharma | Fremgangsmåde til behandling af reproduktionssygdomme |
ATE226958T1 (de) * | 1993-09-20 | 2002-11-15 | Celtrix Pharma | Behandlung von hematologischen störungen mit einem igf-1/igfbp-3 komplex |
JPH09509141A (ja) * | 1993-11-15 | 1997-09-16 | セルトリックス ファーマシューティカルズ,インコーポレイテッド | Igf‐iおよびigfbp‐3を投与することによる腎臓疾患処置の方法 |
CA2176708A1 (en) * | 1993-11-15 | 1995-05-26 | Christopher A. Maack | Method of treating neurological disorders |
EP0800530A4 (de) * | 1994-07-20 | 1998-12-02 | Celtrix Pharma | Igf/igfbp-komplex zur förderung der knochenentwicklung und zur regulation des knochenumbaus |
US5741776A (en) * | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
US6436897B2 (en) * | 1998-06-01 | 2002-08-20 | Celtrix Pharmaceuticals, Inc. | Pharmaceutical formulations for IGF/IGFBP |
US6040292A (en) * | 1999-06-04 | 2000-03-21 | Celtrix Pharmaceuticals, Inc. | Methods for treating diabetes |
-
1999
- 1999-06-04 US US09/326,189 patent/US6040292A/en not_active Expired - Lifetime
-
2000
- 2000-05-23 CA CA002373281A patent/CA2373281C/en not_active Expired - Fee Related
- 2000-05-23 AT AT00932729T patent/ATE271880T1/de active
- 2000-05-23 ES ES00932729T patent/ES2222208T3/es not_active Expired - Lifetime
- 2000-05-23 DE DE60012517T patent/DE60012517T2/de not_active Expired - Lifetime
- 2000-05-23 EP EP00932729A patent/EP1183042B1/de not_active Expired - Lifetime
- 2000-05-23 CN CNB008112649A patent/CN1235637C/zh not_active Expired - Fee Related
- 2000-05-23 JP JP2001501244A patent/JP2003501397A/ja active Pending
- 2000-05-23 MX MXPA01013384A patent/MXPA01013384A/es active IP Right Grant
- 2000-05-23 AU AU50411/00A patent/AU780400B2/en not_active Ceased
- 2000-05-23 IL IL14686800A patent/IL146868A0/xx not_active IP Right Cessation
- 2000-05-23 WO PCT/US2000/014163 patent/WO2000074710A2/en active IP Right Grant
- 2000-05-23 KR KR1020017015628A patent/KR100694737B1/ko not_active IP Right Cessation
-
2001
- 2001-12-04 NO NO20015932A patent/NO324117B1/no not_active IP Right Cessation
- 2001-12-19 ZA ZA200110408A patent/ZA200110408B/xx unknown
-
2002
- 2002-09-02 HK HK02106479A patent/HK1044895A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1183042A2 (de) | 2002-03-06 |
CA2373281C (en) | 2010-01-12 |
ES2222208T3 (es) | 2005-02-01 |
DE60012517T2 (de) | 2005-08-04 |
NO20015932L (no) | 2002-01-31 |
EP1183042B1 (de) | 2004-07-28 |
CN1235637C (zh) | 2006-01-11 |
NO20015932D0 (no) | 2001-12-04 |
WO2000074710A3 (en) | 2001-06-28 |
US6040292A (en) | 2000-03-21 |
MXPA01013384A (es) | 2003-09-04 |
CN1387440A (zh) | 2002-12-25 |
KR20020020723A (ko) | 2002-03-15 |
AU5041100A (en) | 2000-12-28 |
KR100694737B1 (ko) | 2007-03-14 |
IL146868A0 (en) | 2002-08-14 |
ZA200110408B (en) | 2003-03-19 |
DE60012517D1 (de) | 2004-09-02 |
CA2373281A1 (en) | 2000-12-14 |
WO2000074710A2 (en) | 2000-12-14 |
HK1044895A1 (en) | 2002-11-08 |
NO324117B1 (no) | 2007-08-27 |
AU780400B2 (en) | 2005-03-17 |
JP2003501397A (ja) | 2003-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60012517D1 (de) | Methoden zur behandlung von diabetes | |
ATE503490T1 (de) | Monodisperse mischungen und verfahren zur behandlung von diabetes | |
DE69521796T2 (de) | Behandlung des partiellen wachstumshormon-unempfindlichkeitssyndromes | |
DK0915910T3 (da) | Exendin-analoger, fremgangsmåder til fremstilling deraf samt lægemidlter der indeholder disse | |
MXPA04001525A (es) | Analogos de peptido -1 similar al glucagon. | |
ATE462427T1 (de) | Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren | |
DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
MY132626A (en) | CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS | |
MXPA02012203A (es) | Analogos de peptido 1 tipo glucagon. | |
BR0308904A (pt) | Método de tratamento de gastroparesia, e, uso de um composto de glp-1 | |
ATE93138T1 (de) | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. | |
DE59308848D1 (de) | Anwendung von urodilatin bei lungen- und bronchialerkrankungen | |
DE69711078D1 (de) | Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz | |
DE69924979D1 (de) | Behandlung von chronischen schmerzen | |
ATE262362T1 (de) | Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung | |
DE60033569D1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
ATE357914T1 (de) | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien | |
DE60020729D1 (de) | Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen | |
DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
SE9303068D0 (sv) | New use | |
DE60128084D1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl | |
NZ514691A (en) | Method to type prion proteins | |
UA32295A (uk) | Спосіб лікування порушень фертильності у хворих на цукровий діабет | |
MX9710291A (es) | Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos. | |
GEP19991688B (en) | Method for Treatment of Diabetes Mellitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1183042 Country of ref document: EP |